Evidence map›Paper›PMID 35386348›Full record

ArticleBioactive materials2022

Stem cell-laden hydrogel bioink for generation of high resolution and fidelity engineered tissues with complex geometries.

Oju Jeon, Yu Bin Lee, Sang Jin Lee, Nazilya Guliyeva, Joanna Lee, Eben Alsberg

Abstract read
In one paragraph

Article in Bioactive materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oju JeonDepartment of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.
Yu Bin LeeDepartment of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.
Sang Jin LeeDepartment of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.
Nazilya GuliyevaDepartment of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.
Joanna LeeDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL, 60607, USA.
Eben AlsbergDepartment of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, 3D bioprinting has been explored as a promising technology for biomedical applications with the potential to create complex structures with precise features. Cell encapsulated hydrogels composed of materials such as gelatin, collagen, hyaluronic acid, alginate and polyethylene glycol have been widely used as bioinks for 3D bioprinting. However, since most hydrogel-based bioinks may not allow rapid stabilization immediately after 3D bioprinting, achieving high resolution and fidelity to the intended architecture is a common challenge in 3D bioprinting of hydrogels. In this study, we have utilized shear-thinning and self-healing ionically crosslinked oxidized and methacrylated alginates (OMAs) as a bioink, which can be rapidly gelled by its self-healing property after bioprinting and further stabilized via secondary crosslinking. It was successfully demonstrated that stem cell-laden calcium-crosslinked OMA hydrogels can be bioprinted into complicated 3D tissue structures with both high resolution and fidelity. Additional photocrosslinking enables long-term culture of 3D bioprinted constructs for formation of functional tissue by differentiation of encapsulated human mesenchymal stem cells.

Indexed as

3D bioprintingBiomaterialHigh resolution and fidelityHydrogel bioink

Identifiers

PMID35386348
PMCPMC8940765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.